FDA Pushes for 7-OH Control Amid Rising Availability

The FDA recommends the scheduling of 7-OH as a controlled substance due to its prevalence in vapes, drinks, and gummies. FDA Commissioner Marty Makary announced these plans aimed at enhancing regulations to protect public health, especially for children exposed to these products.


Devdiscourse News Desk | Washington DC | Updated: 29-07-2025 20:39 IST | Created: 29-07-2025 20:39 IST
FDA Pushes for 7-OH Control Amid Rising Availability
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • United States

In a decisive move to regulate emerging substances, the U.S. Food and Drug Administration has proposed the classification of the 7-OH compound as a controlled substance. This recommendation was spearheaded by FDA Commissioner Marty Makary during a recent news conference.

Commissioner Makary emphasized the wide availability of 7-OH, which is frequently found in vape stores and diverse consumer products like drinks and children's gummies. The recommendation reflects growing concerns over public health and safety.

The FDA's proposal urges the Drug Enforcement Administration to take swift action in regulating 7-OH. This initiative is particularly focused on preventing inadvertent consumption by children through products marketed to younger audiences.

(With inputs from agencies.)

Give Feedback